"Study finds cardiac threats in revamped antipsychotic drugs; Medicine seen as posing same risk as older versions" by Elizabeth Cooney, Globe Correspondent | January 15, 2009
Newer medications designed to treat serious mental illnesses such as schizophrenia and bipolar disorder without troubling side effects pose the same risk of sudden cardiac death as older drugs, a new study shows.
The findings about the newer, or "atypical," drugs spur a call for closer monitoring of their use, especially when prescribed for other conditions....
I NEVER LIKED THAT IDEA!!! It's like using a saw to hammer a nail. Do yourself a favor, readers, and GO NATURAL!!!!
Drug specialists from Harvard Medical School urge a sharp reduction in the drug's off-label use, which means prescriptions written for a use other than one for which the drug is approved. That was seen as especially important for children and for the elderly with dementia....
Yeah, but THEY CARE about YOUR HEALTH, not $$$, right?
--more--"
SOUTHFIELD, Mich. -.... Zyprexa, used to treat schizophrenia and bipolar disorder, had sales of $4.76 billion in 2007, accounting for about a quarter of Lilly's revenue. The drug, part of a class of medications called atypical antipsychotics, has been linked to excessive weight gain and diabetes.
--more--"
How come the SIDE EFFECTS are always WORSE than the ILLNESS?
